Ovarian cancer: identifying and managing familial and genetic risk
In development [GID-NG10225] Expected publication date: 13 March 2024
Search results
65 results
-
-
Vitamin B12 deficiency, including pernicious anaemia: diagnosis and management
In development [GID-NG10176] Expected publication date: 01 November 2023
-
Asthma: diagnosis, monitoring and chronic asthma management
In development [GID-NG10186] Expected publication date: 15 November 2023
-
Setmelanotide for treating obesity caused by LEPR or POMC deficiency [ID3764]
In development [GID-HST10034] Expected publication date: 20 July 2022
-
Otitis media with effusion in under 12s
In development [GID-NG10193] Expected publication date: 28 September 2023
-
Intrapartum care for healthy women and babies (update)
In development [GID-NG10174] Expected publication date: 16 August 2023
-
Urinary tract infection in under 16s: diagnosis and management
In development [GID-NG10259] Expected publication date: 27 July 2022
-
Haemochromatosis
In development [GID-NG10287] Expected publication date: 02 October 2024
-
Diabetic foot problems: prevention and management (update)
In development [GID-NG10285] Expected publication date: 18 January 2023
-
Eladocagene exuparvovec for treating aromatic L-amino acid decarboxylase deficiency [ID3791]
In development [GID-HST10052] Expected publication date: 29 March 2023
-
Type 2 diabetes in adults: management (medicines update)
In development [GID-NG10336] Expected publication date: TBC
-
Preterm labour and birth
In development [GID-NG10245] Expected publication date: 23 June 2022
-
Head injury: assessment and early management
In development [GID-NG10164] Expected publication date: 23 February 2023
-
Sebelipase alfa for treating Wolman disease [ID3995]
In development [GID-HST10047] Expected publication date: TBC
-
Velmanase alfa for treating alpha-mannosidosis [ID800]
In development [GID-HST10010] Expected publication date: TBC
-
Eteplirsen for treating Duchenne muscular dystrophy [ID1003]
In development [GID-HST10007] Expected publication date: TBC
-
Atopic Dermatitis (Eczema)
In development [GID-NG10289] Expected publication date: TBC
-
Stroke rehabilitation in adults
In development [GID-NG10175] Expected publication date: 18 October 2023
-
Weight Management: preventing, assessing and managing overweight and obesity (update)
In development [GID-NG10182] Expected publication date: 22 June 2023
-
Drisapersen for the first-line treatment of Duchenne's muscular dystrophy [ID911]
In development [GID-HST10004] Expected publication date: TBC
-
Skin abscess: antimicrobial prescribing
In development [GID-NG10163] Expected publication date: TBC
-
Conjunctivitis: antimicrobial prescribing
In development [GID-NG10166] Expected publication date: TBC
-
Blepharitis: antimicrobial prescribing
In development [GID-NG10168] Expected publication date: TBC
-
Stye: antimicrobial prescribing
In development [GID-NG10167] Expected publication date: TBC
-
Tofersen for treating amyotrophic lateral sclerosis caused by SOD1 gene mutations [ID3767]
In development [GID-HST10050] Expected publication date: TBC
-
Osteoporosis: assessing the risk of fragility fracture
In development [GID-NG10216] Expected publication date: 21 February 2024
-
Barrett's oesophagus and stage 1 oesophageal adenocarcinoma: monitoring and management
In development [GID-NG10165] Expected publication date: 23 January 2023
-
Arimoclomol for treating Niemann-Pick disease Type C [ID1312]
In development [GID-HST10037] Expected publication date: TBC
-
Epilepsies in adults: diagnosis and management update (Please see Epilepsies in children, young people and adults)
In development [GID-NG10110] Expected publication date: TBC
-
Maralixibat for treating type 2 progressive familial intrahepatic cholestasis ID3818
In development [GID-HST10040] Expected publication date: TBC
-
Human alpha1-proteinase inhibitor for treating emphysema ID856
In development [GID-HST10017] Expected publication date: TBC
-
Afamelanotide for treating erythropoietic protoporphyria [ID927]
In development [GID-HST10009] Expected publication date: TBC
-
Palovarotene for treating flare ups of heterotopic ossification associated with fibrodysplasia ossificans progressiva [ID2721]
In development [GID-HST10033] Expected publication date: TBC
-
Rehabilitation for chronic neurological disorders including acquired brain injury
In development [GID-NG10181] Expected publication date: 13 December 2023
-
Cardiovascular disease: risk assessment and reduction, including lipid modification
In development [GID-NG10178] Expected publication date: 19 April 2023
-
Diabetes update
In development [GID-NG10152] Expected publication date: TBC
-
Adrenal insufficiency: acute and long-term management
In development [GID-NG10237] Expected publication date: 11 April 2024
-
Harmful gambling: identification, assessment and management
In development [GID-NG10210] Expected publication date: 07 February 2024
-
Metastatic spinal cord compression in adults: risk assessment, diagnosis and management
In development [GID-NG10185] Expected publication date: 23 August 2023
-
Delirium: prevention, diagnosis and management
In development [GID-NG10332] Expected publication date: 09 February 2023
-
Diabetic retinopathy
In development [GID-NG10256] Expected publication date: 03 April 2024
-
Diabetes (type 1 and type 2) in children and young people: diagnosis and management - medicines for type 2 diabetes (update)
In development [GID-NG10286] Expected publication date: 03 January 2024
-
Multiple sclerosis in adults: management
In development [GID-NG10153] Expected publication date: 15 June 2022
-
Meningitis (bacterial) and meningococcal septicaemia: recognition, diagnosis and management
In development [GID-NG10149] Expected publication date: 07 December 2023
-
Depression in adults: treatment and management (update)
In development [GID-CGWAVE0725] Expected publication date: 29 June 2022
-
Sepsis
In development [GID-NG10310] Expected publication date: TBC
-
Melanoma: assessment and management
In development [GID-NG10155] Expected publication date: 27 July 2022
-
Hip fracture: management (update)
In development [GID-NG10280] Expected publication date: 12 October 2022
-
Subarachnoid haemorrhage due to ruptured aneurysms
In development [GID-NG10097] Expected publication date: TBC
-
Ataluren for treating Duchenne muscular dystrophy with a nonsense mutation in the dystrophin gene (review of HST3) ID1642
In development [GID-HST10044] Expected publication date: 25 January 2023